Re: Been wondering
|
6
|
Resverlogix Corp.
|
Aug 19, 2019 07:33PM
|
Re: BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
|
2
|
Zenith Epigenetics
|
Feb 06, 2019 09:52AM
|
Re: BET bromodomain protein inhibitors and AML
|
3
|
Zenith Epigenetics
|
Aug 30, 2017 07:17AM
|
Re: BET bromodomain protein inhibitors and AML
|
3
|
Zenith Epigenetics
|
Aug 30, 2017 05:08PM
|
Re: BET inhibition and epilepsy
|
4
|
Resverlogix Corp.
|
Jun 11, 2021 05:52PM
|
Re: BET inhibition and epilepsy
|
6
|
Resverlogix Corp.
|
Jun 08, 2021 10:13AM
|
Re: BET inhibition in renal and cardiovascular disease: What is the clinical roadmap? VIDEO
|
2
|
Resverlogix Corp.
|
Jun 23, 2017 10:57AM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
5
|
Resverlogix Corp.
|
Sep 25, 2017 10:19PM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
5
|
Resverlogix Corp.
|
Sep 26, 2017 05:19AM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
4
|
Resverlogix Corp.
|
Sep 26, 2017 07:52AM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
2
|
Resverlogix Corp.
|
Sep 23, 2017 08:02PM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
7
|
Resverlogix Corp.
|
Sep 24, 2017 01:52PM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 25, 2017 10:36AM
|
Re: BET inhibitors and Pulmonary Hypertension
|
8
|
Resverlogix Corp.
|
Aug 01, 2018 02:03PM
|
Re: BET inhibitors and Pulmonary Hypertension
|
4
|
Resverlogix Corp.
|
Aug 01, 2018 02:33PM
|
Re: BET inhibitors promising therapy for rare pediatric brain tumor
|
4
|
Zenith Epigenetics
|
Mar 01, 2017 12:48PM
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
6
|
Resverlogix Corp.
|
Dec 05, 2017 02:22PM
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
3
|
Resverlogix Corp.
|
Dec 05, 2017 08:22PM
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
2
|
Resverlogix Corp.
|
Dec 08, 2017 12:41PM
|
Re: betonmace
|
|
Resverlogix Corp.
|
Oct 07, 2016 07:57PM
|